Upload
port
View
1
Download
0
Embed Size (px)
Citation preview
TheAspergillus fumigatus cellobiohydrolaseB (cbhB )promoteris tightly regulatedand can be exploited for controlled proteinexpressionandRNAiMichael Bromley, Caroline Gordon, Nurıa Rovira-Graells & Jason Oliver
F2G Ltd, Lankro Way, Eccles, Manchester, UK
Correspondence: Michael Bromley, F2G Ltd.
Lankro Way, Eccles, Manchester, M30 0BH,
UK. Tel.: 144 161 785 1276; fax: 144 161
785 1273; e-mail: [email protected]
Received 7 July 2006; revised 23 August 2006;
accepted 24 August 2006.
First published online 19 September 2006.
DOI:10.1111/j.1574-6968.2006.00462.x
Editor: Bernard Prior
Keywords
Aspergillus fumigatus ; cbhB ;
cellobiohydrolase; RNAi; promoter.
Abstract
The utility of the Aspergillus fumigatus cellobiohydrolase cbhB promoter for
controlled gene expression has been investigated. cbhB message was present at high
levels in the presence of carboxymethylcellulose and undetected in the presence of
glucose. A reporter construct using the cbhB promoter showed similar behaviour
and gave lower message levels than the Aspergillus nidulans alcA promoter under
repressing conditions. An RNAi construct driven by the cbhB promoter was used to
down-regulate the alb1 gene; transformants showed low alb1 message levels and a
loss-of-function phenotype with carboxymethylcellulose, while both wild-type
message levels and phenotype were seen with glucose. The cbhB promoter is
therefore tightly controlled and can be exploited for the study of A. fumigatus.
Introduction
In recent years, the filamentous fungus Aspergillus fumigatus
has become a significant cause of infection in humans and as
such has become the focus of much study (Latge, 2001; Marr
et al., 2002). It is thought to be the leading mould pathogen
in leukaemia and transplant patients and is responsible for
mortality in a large number of individuals with immunolo-
gical disorders. Until quite recently, the ‘gold standard’
treatment for aspergillus infection has been the intravenous
application of amphotericin B. However, significant side-
effects, coupled with a poor treatment outcome, have lead to
the search for more efficacious and less toxic drugs. The
available alternatives, e.g. voriconazole and itraconazole,
show little improvement in outcome but do have fewer
side-effects (Denning, 1996; Herbrecht et al., 2002). How-
ever, isolates resistant to these azoles have been identified
(Mosquera & Denning, 2002). Current antifungal drugs are
directed against a narrow range of pathways and proteins
and the identification of novel targets is critical in the search
for new antifungal drugs. One aspect of this is the develop-
ment of new target validation technologies. In particular,
improved methods for controlled regulation of genes may be
used to investigate essentiality and therefore determine
whether a gene is suitable as a drug target.
Several inducible promoter systems have been developed
in filamentous fungi, namely the glaA, cbh1, alcA, thiA and
tet systems (Keranen & Penttila, 1995; Siedenberg et al.,
1999; Romero et al., 2003; Mouyna et al., 2004; Shoji et al.,
2005; Vogt et al., 2005); however, significant expression
occurs in repressed or ‘off ’ states. The development of an
inducible system with improved repressing capabilities is
therefore important to enable more complete analysis of
essential genes, particularly those expressed at low levels.
Here, we report studies of a number of A. fumigatus
promoters and show that the promoter for the cellobiohy-
drolase cbhB is tightly controlled, showing high message
levels in the presence of carboxymethylcellulose and low-to-
undetectable levels of message in the presence of glucose.
This represents a substantial improvement over other sys-
tems. We also show that the cbhB promoter is suitable for
protein expression and inducible RNAi studies.
Materials and methods
Aspergillus strains and culture conditions
All methods described used A. fumigatus clinical isolate
AF293 (NCPF7367) available from the NCPF at the Health
Protection Agency, Bristol, UK. Conidia were collected from
FEMS Microbiol Lett 264 (2006) 246–254c� 2006 Federation of European Microbiological SocietiesPublished by Blackwell Publishing Ltd. All rights reserved
4- to 7-day-old cultures grown on Sabouraud Dextrose agar
flasks at 37 1C.
Construction of the expression plasmids andmodified A. fumigatus strains
All primers used for plasmid construction are given in Table
1. The cbhB promoter and terminator were amplified from
A. fumigatus genomic DNA. Primers cbhBp_f and cbhBp_r
were used to amplify a 1.2-kb fragment from � 1 bp of the
ATG codon from the cbhB gene (PcbhB). This fragment was
cloned into the EcoRI site of puc19. Primers cbhBt_f and
cbhBt_r were used to amplify a 0.8 kb from 11 of the TAG
stop from the cbhB gene (TcbhB). This fragment was cloned
into the XbaI site of the puc19-PcbhB plasmid. The hygro-
mycin selectable marker hph was amplified from the pAN7.1
vector using primers hyg_f and hyg_r and cloned into the
NarI site of the puc19-PcbhB-TcbhB plasmid to give plas-
mids pMJB104 and pMJB107 (Fig. 1).
The Escherichia coli lacZ gene was amplified from pDE1
(Fungal Genetics Stock Centre) using primers lacZ-XhoI_f
and lacZ-XhoI_r and cloned into the XhoI site of the pMJB104
and pMJB107 expression cassettes immediately downstream
of the promoter to act as a reporter gene, giving plasmids
pMJB110 and pMJB201, respectively (Fig. 1). The reporter
cassettes were introduced into A. fumigatus AF293 protoplasts
to generate strains AF110-1 and AF110-2 from plasmid
pMJB110 and AF201-1 and AF201-2 from plasmid pMJB201.
0.9 kb of the Aspergillus nidulans alcA promoter
was amplified from plasmid pAL3 (Waring et al., 1989)
Table 1. Primers used in this study
Primer Sequence� Enzyme
Plasmid construction
alcApF GAATTCGTCTGGGCCACAATAGACT EcoRI
alcApR GGTACCTTAAGGTTGTTATCGGTGGGGCGA KpnI
cbhBp_f CAATTGCCCAGGCCTAATGCATGCTG MunIw
cbhBp_r CAATTGCGGTAGGAGAAGGTGGAGGCC MunIw
cbhBt_f TCTAGAGCTAGCATGGGAGTGGTGGCCTCCTCG XbaIz
cbhBt_r ACTAGTCCAGGGGACTGTCGTGGTCAA SpeIz
hyg_f GGCGCCATCGATGTACAGTGACCGGTGACTCT NarI
hyg_r GGCGCCAAGAAGGATTACCTCTAAACA NarI
lacZ-XhoI_f CTCGAGATGGTCGTTTTACAACGTCGTGAC XhoI
lacZ-XhoI_f CTCGAGTTATTATTATTTTTGACACCA XhoI
RNAi_alb1_ant2_F TCTAGAAGCAACGCACGTGCTGCAT XbaI
RNAi_alb1_ant2_R TCTAGAAGCGAGTCCATGCCCATCT XbaI
RNAi_alb1_sense2_F GAGCTCAGCAACGCACGTGCTGCAT SacI
RNAi_alb1_sense2_R CCCGGGAGCGAGTCCATGCCCATCT Cfr9I
RNAi_EGFP_R TCTAGACTTCAGCTCGATGCGGTTC XbaI
RNAi_EGFP_F CCCGGGTCCAGGAGCGCACCATCTT Cfr9I
RT PCR
ACT470F TGGTGTCACTCACGTTGTCC
ACT960R TCATAGACGAGGGAGCAAGG
CBHAF CTCCTCATCCCTGTGACGAT
CBHAR GGCAACGTTGGAGACAGAGT
CBHBF GCTCAGCAGGTCGGTACTTC
CBHBR GCCTGACCGTTGATGAACTT
INVBF TGCGTGCTTCTTTCATTCTC
INVBR TGCGTCTGTAGCGTCTCAGT
Real-time PCR
RtalbF GGAGGATGCTGAGGCTGAC
RtalbR TCGTGTGGGTTGGTGTTGG
RtbtubF GCTCACTCTTTCCGTGCTGTCT
RtbtubR AGCAGGTGAGGTAACGTCCATT
RtcbhBF TTCGATGTCGATGTCTCCAA
RtcbhBR GCCTGACCGTTGATGAACTT
RtlacZF ATCCTCTGCATGGTCAGGTC
RtlacZR TATTGGCTTCATCCACCACA
�For primers including restriction enzyme sites, these are indicated by underlined bases and the enzymes given in the ‘enzyme’ column.wMunI has an overhang compatible with EcoRI.zXbaI and SpeI produce compatible overhangs.
FEMS Microbiol Lett 264 (2006) 246–254 c� 2006 Federation of European Microbiological SocietiesPublished by Blackwell Publishing Ltd. All rights reserved
247The Aspergillus fumigatus cbhB promoter
using primers alcApF and alcApR and cloned directionally
into the puc19 plasmid at the EcoRI and KpnI sites. The
E. coli lacZ gene was amplified as before but with AflII
linkers and introduced downstream of the alcA promoter.
Finally, the hygromycin resistance marker was introduced
into the NarI site as for the cbhB cassette to create
palcA–LacZ (Fig. 1).
The alb1 RNAi construct was produced in a manner
similar to that described in Liu et al. (2002). A sense and
antisense alb1 fragment corresponding to 497 bp of the gene
commencing at position 5142 bp from the start codon were
amplified from A. fumigatus genomic DNA. Primers
RNAi_alb1_sense2_F and RNAi_alb1_sense2_R with SacI
and Cfr9I linkers, respectively, were used to amplify the
sense fragment and primers RNAi_alb1_ant2_F, and
RNAi_alb1_ant2_R, which are the same as the sense primers
but with XbaI linkers, were used to produce the antisense
fragment. A buffer fragment was obtained using primers
RNAi_EGFP_F and RNAi_EGFP_R to amplify a 0.1-kb
fragment of the enhanced green fluorescent protein (EGFP)
gene from the pGFP-zeo plasmid. These fragments were
sequentially cloned into pMJB107 to give plasmid pALBR2
(Fig. 1). This cassette was introduced into A. fumigatus
AF293 protoplasts to generate strains ALBR2 A-D.
HindIII linearized plasmids were introduced into A.
fumigatus AF293 by transformation of protoplasts (D’En-
fert, 1996). Transformants were screened by PCR and only
those strains with complete expression cassettes were used in
further studies. For analysis of cbhB and alcA expression
cassettes, all transformant strains were confirmed to be
single copy by Southern analysis (data not shown).
b-galactosidase assay
1� 106 conidia mL�1 were inoculated into 50 mL of Vogel’s
media, 1% w/v glucose. Cultures were incubated for 14 h at
37 1C with shaking at 220 r.p.m. Biomass was collected and
0.3 g wet weight was used to inoculate Vogel’s media
supplemented with either 1% w/v glucose or 1% w/v
carboxymethylcellulose (CMC). Cultures were incubated
for 2, 4, 6 and 8 h at 37 1C with shaking at 220 r.p.m. for
CMC cultures and 4 h only for the glucose cultures.
Fifty milligrams wet weight biomass was placed in tubes
containing DNA lysing matrix (Bio 101) with 1 mL protein
extraction buffer (50 mM NaH2PO4 pH 7.0, 5 mM EDTA,
10 mM b-mercaptoethanol, 25 g mL�1 PMSF), and samples
were processed in a fastprep FP120 (Bio 101) for 20 s at
speed five. Sample were cooled on ice for 5 min, processed
pMJB201 10 424 bp
TtrpC
Pg
pd
A
PcbhB
LacZ
pALBR2 8453 bp
TtrpC
hph
Pgd
pA
PcbhBalb1
alb1
TcbhB
puc19
pMJB107 7361 bp
TtrpC
Pgpd
A
PcbhB
TcbhB
SpeI
XhoINar I
XbaI
HindIII
HindIII
HindIII
HindIII HindIII
HindIII
pMJB104 7361 bp
Ttrp
C
hph
hph
PgpdA
PcbhB
TcbhB
SpeIXhoI
Nar IXbaI
Nar I Nar I
palcA-LacZ 9267 bp
puc19TtrpC
hph
Pg
pd
A
PalcALacZ
pMJB110 10 424 bp
Pcbh
B
puc19
puc19
LacZ
Ttrp
C
hph
hphPgpdA
puc1
9
puc1
9
Fig. 1. Schematic representation of plasmid constructs. Plasmid pMJB104 shows the cbhB expression cassette in the same orientation as the selectable
marker for hygromycin (hph). In pMJB107, the orientation of the selectable marker is reversed. Plasmids pMJB110 and pMJB201 are derivatives of
pMJB104 and pMJB107 with the Escherichia coli lacZ gene under the control of the cbhB promoter. Plasmid pALBR2 is a derivative of pMJB107 with the
alb1 antisense construct immediately downstream of the cbhB promoter. The antisense construct comprises inverted repeats of alb1 flanking a buffer
sequence (X). Plasmid pAlcA-LacZ shows the AlcA promoter upstream of the E. coli lacZ gene.
FEMS Microbiol Lett 264 (2006) 246–254c� 2006 Federation of European Microbiological SocietiesPublished by Blackwell Publishing Ltd. All rights reserved
248 M. Bromley et al.
again as before and the lysates were placed on ice for 20 min.
Protein extracts were separated from cellular debris by
centrifugation and stored in 200 mL aliquots at � 80 1C.
The b-galactosidase assay was performed in 96-well plates
using 100mL sample or standard (E. coli b-galactosidase,
Sigma) in protein extraction buffer and 100 mL ortho-
nitrophenol-b-D-galactoside (2 mg mL�1). Samples were in-
cubated at 37 1C for 1 h and then read at 415 nm.
Reverse Transcription-PCR analysis
1� 106 conidia mL�1 were inoculated into 50 mL of Vogel’s
media with 1% w/v glucose, 1% w/v sucrose or 1%
carboxymethylcellulose. Total RNA was extracted using the
FastRNA kit (QBIOgene) following the manufacturer’s in-
structions. cDNA was synthesized from 1 mg RNA using an
Avian Myeloblastosis Virus-Reverse Transcriptase kit (Pro-
mega) with random hexamers. Semi-quantitative PCR was
carried out using appropriate dilutions of cDNA and
primers; actin, ACT470F and ACT960R; invB, INVBF and
INVBR; cbhA, CBHAF and CBHAR; and cbhB, CBHBF and
CBHBR (Table 1). All PCRs comprised 30 cycles of 95 1C
1 min, 55 1C 1.5 min and 72 1C 1 min.
Real-time PCR analysis
cDNA was prepared as described above. The growth condi-
tions were as described in ‘b-galactosidase assay’, with
samples taken after 4 h. Reactions were carried out in an
iCycler thermal cycler fitted with an iQ real-time PCR
Detection System (BioRad) running iCycler iQ Optical
System software (version 3a, BioRad). PCRs were typically
performed in triplicate in 96-well plates with each 25 mL
reaction containing 12.5 mL iQ SYBR Green Super-mix
(BioRad), 5 pmol of each primer (Table 1) and 50 ng
template cDNA. PCR conditions were 3 min at 95 1C then
60 cycles of 30 s at 95 1C, 30 s at 55 1C and 15 s at 72 1C.
Fluorescence was measured at the end of the annealing step.
Average Ct points were calculated and the DDCt method
(Pfaffl, 2001) was used to calculate the relative expression
represented by the equation:
EDCtLacZðrepressed-inducedÞLacZ =E
DCtb-tubulinðrepressed-inducedÞb-tubulin :
Results
Regulation of the cellobiohydrolase andinvertase genes
Many of the fungal cellulases and invertases are known to be
regulated by carbon catabolite repression, via the creA-
mediated pathway. Initial experiments assessed the expres-
sion of candidate genes under conditions thought likely to
induce and repress.
Semi-quantitative PCR was used to assess the expression
of the invertase gene invB (Afu2g01240) from mycelia grown
in Vogel’s media using either 1% glucose or 1% sucrose as
the sole carbon source. At the 12-h time-point, products
were detected for invB at cDNA dilutions down to one in
5000 in the presence of sucrose and one in 500 in the
presence of glucose, indicating a 10-fold difference in invB
expression on sucrose compared with glucose, with expres-
sion still clearly visible on glucose (Fig. 2a). No difference
could be seen in the glucose and sucrose samples by the 16
and 24 h time-points (data not shown). Similar analysis was
CMC
cbhA
cbhB
Actin
cDNA dilutions
N − +
Glucose
cbhA
cbhB
Actin
(b)
Glucose
Sucrose
invB
Actin
invB
Actin
(a)
cDNA dilutions
N − +
cDNA dilutions
N − +
cDNA dilutions
N − +
Fig. 2. Regulation of invB, cbhA and cbhB genes by carbon sources.
Agarose gels showing semi-quantitative PCR using (a) invB primer sets on
cDNA samples from 1% (w/v) sucrose and glucose (Vogel’s) cultures after
12 h (b) cbhA and cbhB primer sets on cDNA samples from 1% CMC and
glucose (Vogel’s) cultures after 16 h. PCR was performed on actin as a
control to ensure that comparative levels of cDNA were present between
samples. Negative reverse transcriptase cDNA controls were performed
to demonstrate that there was no genomic DNA contamination.
FEMS Microbiol Lett 264 (2006) 246–254 c� 2006 Federation of European Microbiological SocietiesPublished by Blackwell Publishing Ltd. All rights reserved
249The Aspergillus fumigatus cbhB promoter
conducted for the invA gene (Afu6g05000) but no difference
could be seen at any time-point (data not shown).
Levels of mRNA for cbhA (Afu6g07070) and cbhB
(Afu6g11610) were determined for cultures grown in Vogel’s
media with either 1% glucose or 1% CMC as the sole carbon
source. Expression of both genes was detected at 16 h in
cultures grown with CMC, the cbhA gene being expressed c.
50-fold higher than the cbhB gene (Fig. 2b). No message
could be detected for cbhB in the presence of glucose at 16 h
even after extending the number of PCR cycles to 60. Low
levels of expression, representing an approximate 1000-fold
reduction on the CMC grown levels, were detected for cbhA
in glucose-grown cultures. Similar results were seen at 24 h
(data not shown). Insufficient biomass was obtained at the
12 h time-point to provide analysis. The promoter of the cbhB
gene therefore showed optimal expression characteristics and
was chosen for the development of an inducible system.
Reporter gene analysis of the cellobiohydrolaseB promoter
In filamentous fungi, transcriptional cis-acting elements are
generally thought to be restricted to 1 kb upstream of the
initiation codon (Punt et al., 1995). Therefore, 1.2 kB of the
cbhB upstream-regulatory region was amplified by PCR and
used in analysis of the promoter. Two plasmids were
constructed using the cbhB promoter coupled to the lacZ
reporter gene with the hygromycin marker gene hph, under
control of the strong gpdA promoter, in opposite orienta-
tions (Fig. 1). These constructs were used to transform
A. fumigatus strain AF293. Transformant strains AF110-1 and
AF110-2 from plasmid pMJB110 and strains AF201-1 and
AF201-2 from plasmid pMJB201 were selected for further
analysis. None of the strains showed any obvious phenotypic
variation from the wild-type strain and each carried only a
single copy of the transforming plasmid (data not shown).
To study the regulation of the cbhB promoter over time, b-
galactosidase activity was determined in crude protein extracts
from mycelia. Low levels of native b-galactosidase activity were
detected in the wild-type strain AF293, reaching a maximum
of around 0.9 U mg�1 of protein 8 h after transfer to CMC
(Fig. 3). No activity could be detected after 4 h on glucose.
For transformant strains AF110-1 and AF110-2, b-galac-
tosidase activity significantly above basal levels could be seen
after only 2 h on CMC and activity increased dramatically at
the 4-h time-point (Fig. 3). In comparison, no activity could
be detected in the 4-h glucose sample. The cbhB reporter
construct is therefore regulated in a manner similar to the
endogenous gene. Interestingly, transformants that were
generated using the pMJB201 plasmid, in which the cbhB
promoter is divergent from the selectable marker, showed
no b-galactosidase activity above basal levels even in the
presence of CMC (Fig. 2).
mRNA levels in transformant strains
To determine whether the absence of b-galactosidase activity
in pMJB201 transformant strains (AF201-1 and -2) repre-
sented inactivity of the promoter, quantitative analysis of
mRNA levels were performed using real-time PCR. Cultures
were grown as for the b-galactosidase activity experiment
and samples was taken 4 h after transfer to CMC or glucose.
Expression of the reporter gene could be detected in both
pMJB110-transformed strains (AF110-1 and -2) and
pMJB201-transformed strains (AF201-1 and -2). AF110-1
and -2 transformants on CMC showed lacZ levels that were
approximately a third of the control b-tubulin level; how-
ever, expression could still be detected on glucose at values c.
0.0
2.0
4.0
6.0
8.0
10.0
12.0
Af293 AF110-1 AF110-2 AF201-1 AF201-2
β-G
alac
tosi
das
e ac
tivi
ty f
rom
cru
de
pro
tein
ext
ract
s (U
mg
)
Glucose 4 h
CMC 2 h
CMC 4 h
CMC 6 h
CMC 8 h
Fig. 3. b-galactosidase activity of crude
protein extracts from wild-type (AF293) and
transformant AF110-1, -2, AF201-1 and -2
strains. After incubation for 14 h in 1% glucose
cultures, 0.3 g wet weight biomass was
transferred to fresh cultures. Samples were taken
from either 1% glucose (4 h after transfer) or 1%
CMC (2, 4, 6 or 8 h after transfer) cultures.
FEMS Microbiol Lett 264 (2006) 246–254c� 2006 Federation of European Microbiological SocietiesPublished by Blackwell Publishing Ltd. All rights reserved
250 M. Bromley et al.
100-fold lower than that on CMC (Fig. 4a). In AF201-1 and
AF201-2, lacZ expression was c. 300-fold less than b-tubulin
levels on CMC, accounting for the inability to detect b-
galactosidase activity in these strains. On glucose, lacZ
expression was c. 100-fold lower than on CMC, 30 000-fold
less than the b-tubulin levels (Fig. 4a).
Expression of the native cbhB could not be detected in any
of the transformed stains on glucose, mirroring the results
from the wild-type strain (data not shown). However, on
CMC expression of cbhB could be clearly seen (Fig. 4a). The
levels of cbhB expression in the highly expressing lacZ strains
AF110-1 and -2 were reduced c. fivefold compared with the
AF201-1 and -2 strains, indicating that the activity of the
reporter gene was impacting on the expression levels of the
native cbhB gene (Fig. 4a).
Currently, the most efficient inducible promoter system for
use in Aspergillus strains is the A. nidulans alcA expression
system. We coupled the lacZ reporter cassette to the alcA
promoter to compare directly the alcA and cbhB expression
systems. The expression levels achieved using the alcA pro-
moter were very high and comparable to the expression of
b-tubulin (Fig. 4b). Upon repression, a 76-fold reduction in
expression was seen. The cbhB promoter system gave greater
reduction of expression, with the pMJB110 strains (AF110-1
and -2) giving a 123-fold decrease, while the pMJB201 strains
(AF201-1 and -2) gave a 119-fold decrease. Furthermore, the
actual levels of expression on glucose were much lower for the
cbhB system, particularly pMJB 201 strains.
The cbhB promoter can be used to regulate RNAi
Previous examples of regulated RNAi in A. fumigatus have
shown incomplete recovery of the wild-type phenotype,
presumably due to the leaky nature of the inducible promo-
ters (Romero et al., 2003). The strong regulation exhibited
by the cbhB promoter suggests that it could provide an
improved regulatory element for RNAi.
β-tubulin alcA (ind) alcA (rep) cbhB AF110 CMC
cbhB AF110 glucose
cbhB AF201 CMC
cbhB AF201 glucose
0.00001
0.0001
0.001
0.01
0.1
1
10
AF110-1 AF110-2 AF201-1 AF201-2
Rel
ativ
e ex
pre
ssio
n
0.00001
0.0001
0.001
0.01
0.1
1
10
Rel
ativ
e ex
pre
ssio
n =
1
(a)
(b)Fig. 4. Control of lacZ expression by the cbhB
promoter. (a) Expression levels of cbhB and lacZ
in strains AF110-1, -2, AF201-1 and -2, relative
to that of b-tubulin. After incubation for 14 h
in 1% glucose cultures, 0.3 g wet weight
biomass was transferred to fresh cultures.
Samples were taken 4 h after transfer from
either 1% glucose or 1% CMC cultures.
No expression of the native cbhB gene was
detected in the glucose cultures (not shown).
(b) Expression levels of the lacZ reporter gene
under the control of the alcA promoter of
A. nidulans compared with those seen for the
cbhB promoter. Levels are normalized to that
of b-tubulin. cbhB AF110 data are combined
data from the AF110-1 and -2 strains, while
AF201 data are combined data from the
AF201-1 and -2 strains.
FEMS Microbiol Lett 264 (2006) 246–254 c� 2006 Federation of European Microbiological SocietiesPublished by Blackwell Publishing Ltd. All rights reserved
251The Aspergillus fumigatus cbhB promoter
An RNAi construct under the control of the cbhB
promoter was produced (pALBR2; Fig. 1), targetting the
alb1 gene, which encodes a polyketide synthetase involved in
spore pigmentation (Tsai et al., 1998). In alb1� strains,
conidia have white spores as opposed to the green-blue
appearance of wild-type spores. The RNAi construct was
transcribed divergently from the marker gene hph. Of four
transformants containing the RNAi construct, all showed a
spore colour change on CMC, two (R2B and R2C) having
pure white colonies indicative of complete repression of alb1
(Fig. 5a). On glucose, R2B showed no obvious spore colour
difference compared with the wild-type strain, while R2C
100.0113.3
101.6
1.90
20
40
60
80
100
120
140
160
AF293 Glucose AF293 CMC R2B Glucose R2B CMC
AF
alb
1 re
lati
ve e
xpre
ssio
n
AF293
R2B
R2C
CMCGlucose
(a)
(b) Fig. 5. RNAi of alb1. (a) Phenotypic characteristics
of AF293 and transformant strains R2B and R2C
showing growth on Vogel’s media with either 1%
glucose or 1% CMC as the sole carbon source.
(b) Relative expression levels of alb1 in the AF293
wild-type strain and the transformant strain
R2B harbouring the alb1 RNAi construct. After
incubation for 14 h in 1% glucose cultures,
0.3 g wet weight biomass was transferred to fresh
cultures. Samples were taken 4 h after transfer
from either 1% glucose or 1% CMC cultures.
Expression was normalized to b-tubulin so that
direct comparisons could be made.
FEMS Microbiol Lett 264 (2006) 246–254c� 2006 Federation of European Microbiological SocietiesPublished by Blackwell Publishing Ltd. All rights reserved
252 M. Bromley et al.
presented light green spores indicating partial reduction in
alb1 activity.
Real-time PCR was performed on the R2B strain to assess
expression of alb1 (Fig. 5b). alb1 expression on glucose
matched that of the wild-type strain, indicating that no
RNAi was occurring. On CMC, levels of alb1 expression
were o 2% of that seen in the wild-type strain.
Discussion
We have demonstrated that the cbhB promoter of A. fumiga-
tus is tightly regulated, providing quantitative evidence for
this. Few studies have to date focused on the quantitative
aspects of the control of gene expression by specific gene
promoters in Aspergilli, although this is a prerequisite for the
development of a robust expression system.
Our data for cbhA resemble those reported for the cbhA
gene of A. nidulans, which was induced by cellulose and
repressed by glucose (Lockington et al., 2002). However, the
regulation of the A. nidulans homologue seems to differ in
that it is negatively regulated by the global nitrogen metabo-
lite repression system mediated by areA. In contrast, we were
able to see expression of cbhA despite our experiments being
carried out in Vogel’s medium, which uses ammonium nitrate
as the nitrogen source. This indicates that there are differences
in cbhA regulation between the two species of Aspergillus.
We found that the cbhB promoter gave very low expression
levels on glucose and c. a 100-fold increase in the level of
message on CMC in our reporter strains. In our hands, the A.
nidulans alcA promoter yielded c. an 80-fold increase in level
of induced over repressed, and showed a higher level of gene
expression under repression than cbhB on glucose. The
effectiveness of A. nidulans alcA in A. fumigatus has pre-
viously been studied by Romero et al. (2003). Here, the
endogenous essential nudC gene was placed under the control
of the alcA promoter. Transformants containing the construct
were unable to grow on glucose (repressing conditions) but
could grow on threonine (inducing conditions), indicating
efficient control of the nudC gene. However, as the nudC gene
is essential, is was not possible to determine nudC message
levels under repressing conditions, although partially
repressed conditions gave substantial inhibition, estimated at
3–4% of induced levels. We suggest that if a high level of
control is required, the cbhB system may be more suitable
than alcA. It should be noted that our studies used CMC
as the sole carbon source. For comparative assessment
of growth, CMC alone may not be appropriate as it is such a
poor carbon source. Such studies can, however, be performed
using culture media supplemented with glycerol, as this
does not negatively affect the expression of the cbhB promoter
(M. Bromley, unpublished observation).
Two inducible systems based on noncarbon-based induc-
tion have been reported for use in Aspergilli. The thiA
promoter of A. oryzae is responsible for regulation of
thiamine biosynthesis and is repressed at the transcription
and translation levels by thiamine and has been shown to
regulate egfp expression in A. nidulans as well as A. oryzae
(Shoji et al., 2005). In addition, an E. coli promoter system
based on the tetracycline-resistance operon has been
adapted for use in A. fumigatus (Vogt et al., 2005). This
system provides a significant advance in inducible promoter
systems in filamentous fungi as it has the potential for
regulation during in vivo infection experiments. However,
both these systems share the same problem as the previously
described carbon-based systems in that significant expres-
sion still occurs in repressed or ‘off ’ states.
RNAi is an increasingly important system for the investi-
gation of gene function in fungi; however, little has as yet
been done with a regulated system in the human pathogen
A. fumigatus. Mouyna et al. (2004) used the A. niger glaA
promoter in A. fumigatus to drive RNAi constructs directed
against alb1 and b(1-3) glucan synthase (fks1). While
inhibition was successful, under repressed conditions (xy-
lose), the fks1 construct was found to be leaky, with RNA
levels 25% of those in wild-type strain. In comparison, our
levels on glucose were the same as the wild type. Like us,
Mouyna et al. observed a range of phenotypes on induction,
from partial to full knockout. It was suggested that this
could be due to different sites of integration of the RNAi
construct, leading to variations in the efficiency with which
the construct is expressed. This could be overcome using a
nonintegrative plasmid such as AMA.
For studies of gene function and RNAi experiments in
particular, effective repression is as important a factor as
good levels on induction. Our data indicate that, in A.
fumigatus, cbhB is more suitable than existing promoter
systems and should facilitate the identification of essential
genes in A. fumigatus, thereby contributing to the discovery
of novel anti-fungal drug targets.
Acknowledgements
The authors would like to thank Peter Hey for his technical
assistance. The cbhB promoter system is the subject of patent
application GB602435.
References
D’Enfert C (1996) Selection of multiple disruption events in
Aspergillus fumigatus using the orotidine-50-decarboxylase
gene, pyrG, as a unique transformation marker. Curr Genet 30:
76–82.
Denning DW (1996) Therapeutic outcome in invasive
aspergillosis. Clin Infect Dis 23: 608–615.
FEMS Microbiol Lett 264 (2006) 246–254 c� 2006 Federation of European Microbiological SocietiesPublished by Blackwell Publishing Ltd. All rights reserved
253The Aspergillus fumigatus cbhB promoter
Herbrecht R, Denning DW, Patterson TF et al. (2002)
Voriconazole versus amphotericin B for primary therapy of
invasive aspergillosis. N Engl J Med 347: 408–415.
Keranen S & Penttila M (1995) Production of recombinant
proteins in the filamentous fungus Trichoderma reesei. Curr
Opin Biotechnol 6: 534–537.
Latge JP (2001) The pathobiology of Aspergillus fumigatus. Trends
Microbiol 9: 382–389.
Liu H, Cottrell TR, Pierini LM, Goldman WE & Doering TL
(2002) RNA interference in the pathogenic fungus
Cryptococcus neoformans. Genetics 160: 463–470.
Lockington RA, Rodbourn L, Barnett S, Carter CJ & Kelly JM
(2002) Regulation by carbon and nitrogen sources of a family
of cellulases in Aspergillus nidulans. Fungal Genet Biol 37:
190–196.
Marr KA, Patterson T & Denning D (2002) Aspergillosis.
Pathogenesis, clinical manifestations, and therapy. Infect Dis
Clin North Am 16: 875–894.
Mosquera J & Denning DW (2002) Azole cross-resistance in
Aspergillus fumigatus. Antimicrob Agents Chemother 46:
556–557.
Mouyna I, Henry C, Doering TL & Latge J-P (2004) Gene
silencing with RNA interference in the human pathogenic
fungus Aspergillus fumigatus. FEMS Microbiol Lett 237:
317–324.
Pfaffl MW (2001) A new mathematical model for relative
quantification in real-time RT-PCR. Nucleic Acids Res 29:
2002–2007.
Punt PJ, Strauss J, Smit R, Kinghorn JR, van den Hondel CA &
Scazzocchio C (1995) The intergenic region between the
divergently transcribed niiA and niaD genes of Aspergillus
nidulans contains multiple NirA binding sites which act
bidirectionally. Mol Cell Biol 15: 5688–5699.
Romero B, Turner G, Olivas I, Laboura F & De Lucas JR (2003)
The Aspergillus nidulans alcA promoter drives tightly regulated
conditional gene expression in Aspergillus fumigatus
permitting validation of essential genes in this human
pathogen. Fungal Genet Biol 40: 103–114.
Shoji JY, Maruyama J, Arioka M & Kitamoto K (2005)
Development of Aspergillus oryzae thiA promoter as a tool for
molecular biological studies. FEMS Microbiol Lett 244: 41–46.
Siedenberg D, Mestric S, Ganzlin M, Schmidt M, Punt PJ, van den
Hondel CAMJJ & Rinas U (1999) GlaA promoter controlled
production of a mutant green fluorescent protein (S65T)
by recombinant Aspergillus niger during growth on defined
medium in batch and fed-batch cultures. Biotechnol Progr 15:
43–50.
Tsai HF, Chang YC, Washburn RG, Wheeler MH & Kwon-Chung
KJ (1998) The developmentally regulated alb1 gene of
Aspergillus fumigatus: its role in modulation of conidial
morphology and virulence. J Bacteriol 180: 3031–3038.
Vogt K, Bhabhra R, Rhodes JC & Askew DS (2005) Doxycycline-
regulated gene expression in the opportunistic fungal
pathogen Aspergillus fumigatus. BMC Microbiol 5: 1.
Waring RB, May GS & Norris NR (1989) Characterization of an
inducible expression system in Aspergillus nidulans using alcA
and tubulin-coding genes. Gene 79: 119–130.
FEMS Microbiol Lett 264 (2006) 246–254c� 2006 Federation of European Microbiological SocietiesPublished by Blackwell Publishing Ltd. All rights reserved
254 M. Bromley et al.